Replies to post #213031 on Biotech Values

[jb_118]

I gave serious consideration to at least taking some FGEN shares off the table as it's been my largest holding for a while now. But, I decided to continue to hold in full

I resemble this comment in every aspect. My more costly investing mistakes have been selling too early rather than not taking profits, although I have a few instances of each. I'm willing to wait for the full value of the company to manifest, even if it takes a few years. Still like the risk/reward here relative to other places I could put the money to work.

Roxa China seems underappreciated, and the anti-fibrotic potential might be just unfolding. Still some good potential catalysts to come this year.